Global Oral Typhoid Vaccine Market Is Estimated To Witness High...

Global Oral Typhoid Vaccine Market Is Estimated To Witness High Growth Owing To Increasing Incidences

Posted 2023-10-25 12:20:16

SWOT Analysis:
Strength: The oral typhoid vaccine market is expected to witness high growth due to increasing awareness about the importance of vaccination and the rising prevalence of typhoid fever globally. The market is driven by key players such as Sanofi Pasteur, Bharat Biotech, and Pfizer Inc., who have strong research and development capabilities and an extensive distribution network.

Weakness: One of the weaknesses in the oral typhoid vaccine market is the high cost associated with vaccine development and production, which can limit accessibility in low-income countries. Another weakness is the lack of awareness about typhoid fever and the need for vaccination in some regions, resulting in lower demand for oral typhoid vaccines.

Opportunity: The oral typhoid vaccine market presents opportunities for growth through the expansion of vaccine coverage in emerging economies with a high burden of typhoid fever, such as India and Southeast Asian countries. Additionally, advancements in vaccine technology, such as the development of combination vaccines and needle-free administration methods, can further drive market growth.

Threats: One of the threats in the oral typhoid vaccine market is the presence of alternative methods of typhoid prevention, such as improved sanitation and hygiene practices, which can reduce the demand for vaccines. Another threat is the potential for vaccine hesitancy and misinformation, which can impact vaccine uptake rates and hinder market growth.

Key Takeaways:
The global Oral Typhoid Vaccine Market Share is expected to witness high growth, exhibiting a CAGR of 12.3% over the forecast period of 2023-2030. This growth is primarily driven by increasing awareness about the importance of vaccination and the rising prevalence of typhoid fever globally. The market is dominated by key players such as Sanofi Pasteur, Bharat Biotech, and Pfizer Inc. The Asia Pacific region is expected to be the fastest-growing and dominating region in the oral typhoid vaccine market, attributed to the high burden of typhoid fever in countries like India and Southeast Asian nations.